Early research (Phase 1)Active Not RecruitingNCT06377111What this trial is testingTest the Benefit of Vitamin B5 in Patients With MelanomaWho this might be right forMelanoma (Skin) University Health Network, Toronto 12
Early research (Phase 1)Ended earlyNCT00791271What this trial is testingParallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I PortionWho this might be right forMelanoma M.D. Anderson Cancer Center 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05625399What this trial is testingSubcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 579
Not applicableNo Longer AvailableNCT02416232What this trial is testingAccess Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous MelanomaWho this might be right forMelanoma GlaxoSmithKline
Testing effectiveness (Phase 2)Looking for participantsNCT07280832What this trial is testingPhase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract TumorsWho this might be right forUnresectable Locally Advanced or Metastatic MelanomaUnresectable Locally Advanced or Metastatic Urinary Tract Tumors Shanghai JMT-Bio Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00189332What this trial is testingUse of 852A in Metastatic Cutaneous Melanoma.Who this might be right forMelanomaUnresectable Metatstatic Cutaneous Melanoma Pfizer 28
Early research (Phase 1)Study completedNCT03538314What this trial is testingUV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic MelanomaWho this might be right forMalignant Melanoma Ultimovacs ASA 30
Not applicableNo Longer AvailableNCT00584493What this trial is testingTreatment Use Study for Advanced Melanoma.Who this might be right forAdvanced Unresectable Melanoma Pfizer
Large-scale testing (Phase 3)Active Not RecruitingNCT05352672What this trial is testingClinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic MelanomaWho this might be right forMelanoma Regeneron Pharmaceuticals 1,546
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT03864042What this trial is testingPharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Melanoma Pfizer 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT01989585What this trial is testingTesting the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Malignant Solid Neoplasm+2 more National Cancer Institute (NCI) 75
Testing effectiveness (Phase 2)Study completedNCT00591370What this trial is testingPhase II Trial of Extended-Dosing Temozolomide in Patients With MelanomaWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 51
Early research (Phase 1)Active Not RecruitingNCT01364051What this trial is testingCediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesWho this might be right forMetastatic MelanomaRefractory Malignant Solid NeoplasmStage IV Cutaneous Melanoma AJCC v6 and v7+1 more National Cancer Institute (NCI) 19
Early research (Phase 1)Ended earlyNCT01783431What this trial is testingStudy of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic CellsWho this might be right forMelanoma Medical University of South Carolina 1
Testing effectiveness (Phase 2)Looking for participantsNCT04598009What this trial is testingBinimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant MelanomaWho this might be right forMelanoma Stage IIIMelanoma Stage IV University of California, San Francisco 25
Testing effectiveness (Phase 2)Study completedNCT02583516What this trial is testingClinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic MelanomaWho this might be right forMelanoma Grupo Español Multidisciplinar de Melanoma 70
Large-scale testing (Phase 3)Active Not RecruitingNCT02339571What this trial is testingA Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced MelanomaWho this might be right forStage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7 National Cancer Institute (NCI) 600
Testing effectiveness (Phase 2)Looking for participantsNCT05655312What this trial is testingMC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced MelanomaWho this might be right forRecurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more Perspective Therapeutics 300
Large-scale testing (Phase 3)Study completedNCT03635983What this trial is testingNKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 783